Knowledge mapping and global trends of drug hypersensitivity from 2013 to 2023: A bibliometric analysis.

Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN: 2050-4527 (Electronic) Linking ISSN: 20504527 NLM ISO Abbreviation: Immun Inflamm Dis Subsets: MEDLINE

Original Publication: [Oxford] : John Wiley and Sons Ltd, [2013]-

Drug Hypersensitivity*/epidemiology ; Anaphylaxis*; Humans ; Polyethylene Glycols ; Bibliometrics ; Algorithms

Background: Drug hypersensitivity is a major global public health issue with a significant increase in prevalence in populations. Here, we provide a deep insight into the frontier hotspot and future direction in the field of drug hypersensitivity.
Methods: A knowledge map is portrayed based on publications related to drug hypersensitivity from Web of Science Core Collection using CiteSpace. Co-occurrence relationships of countries, institutes, authors, journals, references, and keywords are constructed. According to the co-occurrence relationships, hotspots and future trends are overviewed.
Results: The United States ranked first in the world and China with the second highest publications was the only developing country. Torres, Mayorga, and Blanca were highly productive authors. Harvard University was the institution with the most research publications. Keywords co-occurrence analysis suggested applications in emerging causes, potential mechanisms, and clinical diagnosis as the research hotspots and development frontiers.
Conclusion: Research on drug hypersensitivity is in a rapid development stage and an emerging trend in reports of anaphylaxis to polyethylene glycols is identified. Developing algorithms for understanding the standardization process of culprit drugs, clinical manifestations, and diagnostic methods will be the focus of future direction. In addition, a better understanding of the mechanisms to culprit drugs with immunological precise phenotypic definitions and high-throughput platforms is needed.
(© 2024 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.)

Med Clin North Am. 2020 Jan;104(1):109-128. (PMID: 31757230)
Int J Mol Sci. 2021 Feb 21;22(4):. (PMID: 33670052)
Neurology. 2017 Jan 3;88(1):78-86. (PMID: 27913699)
Allergy. 2017 Apr;72(4):552-561. (PMID: 27569064)
JAMA. 2014 Aug 6;312(5):525-34. (PMID: 25096692)
Curr Pharm Des. 2016;22(45):6870-6880. (PMID: 27784245)
Lancet. 2019 Jan 12;393(10167):183-198. (PMID: 30558872)
JAMA Dermatol. 2019 Jun 1;155(6):666-672. (PMID: 30916737)
Nature. 2012 Jun 28;486(7404):554-8. (PMID: 22722860)
Immun Inflamm Dis. 2024 Apr;12(4):e1245. (PMID: 38629759)
Int Immunopharmacol. 2022 Jan;102:108389. (PMID: 34920312)
J Allergy Clin Immunol. 2019 Jan;143(1):56-65. (PMID: 30573343)
J Anesth. 2016 Apr;30(2):290-7. (PMID: 26646837)
JAMA. 2019 Jan 15;321(2):188-199. (PMID: 30644987)
Allergy. 2020 Dec;75(12):3112-3123. (PMID: 32990987)
J Immunol Res. 2019 Jan 31;2019:2489429. (PMID: 30838223)
J Allergy Clin Immunol. 2015 Aug;136(2):219-34; quiz 235. (PMID: 26254049)
Curr Allergy Asthma Rep. 2019 Nov 27;19(12):58. (PMID: 31776687)
Allergy. 2020 Jun;75(6):1300-1315. (PMID: 31749148)
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1327-1337.e3. (PMID: 33039642)
J Allergy Clin Immunol. 2019 Jan;143(1):66-73. (PMID: 30573342)
Nature. 2015 Mar 12;519(7542):237-41. (PMID: 25517090)
Int J Med Inform. 2021 Dec;156:104611. (PMID: 34653809)
J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1169-1178. (PMID: 28888247)
Comput Biol Med. 2021 Sep;136:104746. (PMID: 34388468)
J Allergy Clin Immunol. 2004 May;113(5):832-6. (PMID: 15131563)
Sci Rep. 2018 Nov 12;8(1):16710. (PMID: 30420763)
Curr Opin Allergy Clin Immunol. 2021 Apr 1;21(2):168-174. (PMID: 33560740)
J Allergy Clin Immunol Pract. 2020 Oct;8(9S):S16-S116. (PMID: 33039007)
Nat Nanotechnol. 2021 Nov;16(11):1169-1171. (PMID: 34732846)
Pediatr Blood Cancer. 2017 May;64(5):. (PMID: 27786403)
Allergy. 2017 Mar;72(3):498-506. (PMID: 27732743)
Allergy. 2010 Nov;65(11):1357-66. (PMID: 20716314)
Klin Lab Diagn. 2021 Dec 21;66(12):747-754. (PMID: 35020288)
Curr Allergy Asthma Rep. 2021 Jul 7;21(6):37. (PMID: 34232411)
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1287-1296.e1. (PMID: 29100867)
Allergy. 2019 Jun;74(6):1063-1080. (PMID: 30688375)
Allergy. 2014 Jun;69(6):806-9. (PMID: 24673580)
Front Immunol. 2020 Jan 21;10:3143. (PMID: 32038646)
Allergy. 2016 Aug;71(8):1103-34. (PMID: 26991315)
J Allergy Clin Immunol. 2021 Apr;147(4):1402-1412. (PMID: 32791162)
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):108-119. (PMID: 32694094)
JAMA Netw Open. 2019 Dec 2;2(12):e1918007. (PMID: 31860106)
Clin Exp Allergy. 2013 Sep;43(9):1027-37. (PMID: 23957338)
Front Immunol. 2021 Aug 12;12:613461. (PMID: 34456900)
PLoS One. 2013 Oct 07;8(10):e76211. (PMID: 24116097)
Allergy. 2012 Jul;67(7):929-35. (PMID: 22583135)
Allergy. 2022 Dec;77(12):3527-3537. (PMID: 35912413)
Acta Biomed. 2021 Nov 29;92(S7):e2021519. (PMID: 34842597)
J Dermatol Sci. 2012 Jun;66(3):190-6. (PMID: 22541332)
Vaccines (Basel). 2021 Apr 21;9(5):. (PMID: 33919151)
World Allergy Organ J. 2020 Feb 25;13(2):100080. (PMID: 32128023)
Allergol Int. 2019 Jul;68(3):301-308. (PMID: 31000444)
Allergy. 2013 Jun;68(6):702-12. (PMID: 23617635)
Sci Rep. 2016 Mar 31;6:23845. (PMID: 27030298)
J Investig Allergol Clin Immunol. 2020;30(4):229-253. (PMID: 31932268)
J Eur Acad Dermatol Venereol. 2013 Mar;27(3):356-64. (PMID: 22211830)
Acta Haematol. 2020;143(5):496-499. (PMID: 32182610)
Allergy. 2024 Mar;79(3):580-600. (PMID: 38084472)
Nat Commun. 2019 Aug 8;10(1):3569. (PMID: 31395875)
Curr Allergy Asthma Rep. 2014 Jun;14(6):442. (PMID: 24740692)
J Allergy Clin Immunol Pract. 2019 Jan;7(1):219-227.e4. (PMID: 29800753)
Allergy. 2017 Dec;72(12):2039-2043. (PMID: 28658502)
Clin Transl Allergy. 2017 Mar 13;7:7. (PMID: 28293415)
J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):302-304. (PMID: 28958742)
Allergy. 2019 Jan;74(1):14-27. (PMID: 30028512)
Allergy. 2020 Apr;75(4):956-959. (PMID: 31557316)
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1341-1343.e1. (PMID: 30266590)
Curr Allergy Asthma Rep. 2017 Aug;17(8):56. (PMID: 28752367)
J Allergy Clin Immunol Pract. 2021 Feb;9(2):819-829.e2. (PMID: 32992044)
Allergy. 2021 May;76(5):1340-1349. (PMID: 32780486)
Allergy. 2019 Dec;74(12):2368-2381. (PMID: 31557314)
Allergy. 2019 Aug;74(8):1457-1471. (PMID: 30843233)
J Allergy Clin Immunol. 2019 Jul;144(1):183-192. (PMID: 30776417)
World Allergy Organ J. 2020 Oct 30;13(10):100472. (PMID: 33204386)
J Clin Pharmacol. 2021 Jun;61(6):832-835. (PMID: 33543766)
Toxicology. 2021 Nov;463:152971. (PMID: 34606953)
Allergy. 2014 Apr;69(4):420-37. (PMID: 24697291)
J Immunol. 2014 Apr 1;192(7):2984-93. (PMID: 24591375)
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1321-1326. (PMID: 29175371)
Front Pharmacol. 2019 May 21;10:469. (PMID: 31164819)
J Allergy Clin Immunol. 2012 Jan;129(1):263-4; author reply 265-6. (PMID: 21982115)
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3546-3567. (PMID: 34153517)
J Allergy Clin Immunol. 2022 Jan;149(1):168-175.e4. (PMID: 34052265)

2021030 Basic Research Program of Shanxi; 2123314 Basic Research Program of Shanxi; 2022Y373 Postgraduate Education Innovation Project of Shanxi; 81971790 National Natural Science Foundation of China; 82271925 National Natural Science Foundation of China

Keywords: CiteSpace; bibliometric analysis; drug hypersensitivity; knowledge domain visualization

3WJQ0SDW1A (Polyethylene Glycols)

Date Created: 20240417 Date Completed: 20240418 Latest Revision: 20240425

20240425

PMC11022627

10.1002/iid3.1245

38629759